A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
一项评估氟维司群联合阿贝西利治疗激素受体阳性晚期或复发性子宫内膜癌的II期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1999
Green, Angela K; Zhou, Qin; Iasonos, Alexia; Zammarrelli, William A 3rd; Weigelt, Britta; Ellenson, Lora H; Chhetri-Long, Rashmi; Shah, Pooja; Loh, Jade; Hom, Vania; Selenica, Pier; Erinjeri, Joseph; Petkovska, Iva; Chandarlapaty, Sarat; Cohen, Seth; Grisham, Rachel; Konner, Jason; Rubinstein, Maria M; Tew, William; Troso-Sandoval, Tiffany; Aghajanian, Carol; Makker, Vicky